202 related articles for article (PubMed ID: 35720371)
1. P140 Peptide Leads to Clearance of Autoreactive Lymphocytes and Normalizes Immune Response in Lupus-Prone Mice.
Schall N; Talamini L; Wilhelm M; Jouvin-Marche E; Muller S
Front Immunol; 2022; 13():904669. PubMed ID: 35720371
[TBL] [Abstract][Full Text] [Related]
2. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.
Page N; Gros F; Schall N; Décossas M; Bagnard D; Briand JP; Muller S
Ann Rheum Dis; 2011 May; 70(5):837-43. PubMed ID: 21173017
[TBL] [Abstract][Full Text] [Related]
3. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
[TBL] [Abstract][Full Text] [Related]
4. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.
Page N; Schall N; Strub JM; Quinternet M; Chaloin O; Décossas M; Cung MT; Van Dorsselaer A; Briand JP; Muller S
PLoS One; 2009; 4(4):e5273. PubMed ID: 19390596
[TBL] [Abstract][Full Text] [Related]
5. Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression.
Wilhelm M; Wang F; Schall N; Kleinmann JF; Faludi M; Nashi EP; Sibilia J; Martin T; Schaeffer E; Muller S
Arthritis Rheumatol; 2018 Jul; 70(7):1077-1088. PubMed ID: 29499102
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells.
Page N; Gros F; Schall N; Briand JP; Muller S
Autophagy; 2011 May; 7(5):539-40. PubMed ID: 21282971
[TBL] [Abstract][Full Text] [Related]
7. [Autophagy, autoimmunity and autoimmune diseases].
Muller S
Med Sci (Paris); 2017 Mar; 33(3):319-327. PubMed ID: 28367820
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
Wang F; Tasset I; Cuervo AM; Muller S
Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
[TBL] [Abstract][Full Text] [Related]
9. Resetting the autoreactive immune system with a therapeutic peptide in lupus.
Schall N; Muller S
Lupus; 2015 Apr; 24(4-5):412-8. PubMed ID: 25801884
[TBL] [Abstract][Full Text] [Related]
10. Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option.
Bonam SR; Wang F; Muller S
J Autoimmun; 2018 Nov; 94():16-32. PubMed ID: 30219390
[TBL] [Abstract][Full Text] [Related]
11. Adamantane-based dendrons for trimerization of the therapeutic P140 peptide.
Lamanna G; Grillaud M; Macri C; Chaloin O; Muller S; Bianco A
Biomaterials; 2014 Aug; 35(26):7553-61. PubMed ID: 24889033
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of peptide P140 in a mouse periodontitis model.
Akiyama K; Aung KT; Talamini L; Huck O; Kuboki T; Muller S
Cell Mol Life Sci; 2022 Sep; 79(10):518. PubMed ID: 36104457
[TBL] [Abstract][Full Text] [Related]
13. HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates.
Bonam SR; Ruff M; Muller S
Cells; 2019 Aug; 8(8):. PubMed ID: 31394830
[TBL] [Abstract][Full Text] [Related]
14. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
Monneaux F; Lozano JM; Patarroyo ME; Briand JP; Muller S
Eur J Immunol; 2003 Feb; 33(2):287-96. PubMed ID: 12548559
[TBL] [Abstract][Full Text] [Related]
15. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.
Kang HK; Ecklund D; Liu M; Datta SK
Arthritis Res Ther; 2009; 11(2):R59. PubMed ID: 19405952
[TBL] [Abstract][Full Text] [Related]
16. Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide.
Maueröder C; Schall N; Meyer F; Mahajan A; Garnier B; Hahn J; Kienhöfer D; Hoffmann MH; Muller S
Front Immunol; 2017; 8():16. PubMed ID: 28191006
[TBL] [Abstract][Full Text] [Related]
17. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
18. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan C; Adams S; Stanik V; Datta SK
J Exp Med; 1993 May; 177(5):1367-81. PubMed ID: 8478612
[TBL] [Abstract][Full Text] [Related]
19. The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis.
Bendorius M; Neeli I; Wang F; Bonam SR; Dombi E; Buron N; Borgne-Sanchez A; Poulton J; Radic M; Muller S
Front Immunol; 2018; 9():2158. PubMed ID: 30319621
[TBL] [Abstract][Full Text] [Related]
20. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
